Novavax gains on vaccine deal

Novavax Inc. (NASDAQ:NVAX) gained $0.78 (31%) to $3.28 on Tuesday after announcing an initial agreement to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceu...